ABBOTT's TRANXENE "ANXIOSELECTIVE" PROMOTION ENDING: FDA SAYS NO CLINICALLY SIGNIFICANT DIFFERENCE EXISTS BETWEEN TRANXENE & OTHER ANXIOLYTICS